ArticleProceedings. IEEE International Conference on Bioinformatics and Biomedicine2025
Modeling TCR-pMHC Binding with Dual Encoders and Cross-Attention Fusion.
Article in Proceedings. IEEE International Conference on Bioinformatics and Biomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- When multimodal fusion fails: contrastive alignment as a necessary stabilizer for TCR-peptide binding prediction.Bioinformatics (Oxford, England) · 2026Article
- LANTERN: TCR-peptide binding predictionPeerJ · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Accurately modeling the binding between T-cell receptors (TCRs) and peptide-MHC (pMHC) complexes is essential for guiding immunotherapy development and personalized vaccine design. However, the vast diversity of TCR repertoires and the scarcity of experimentally validated interactions make generalization to unseen epitopes challenging. This paper proposes TIDE, a cross-attention-driven dual-encoder framework that leverages large protein and molecular language models to learn discriminative representations of TCRs and peptides. In TIDE, TCR sequences are encoded using Evolutionary Scale Modeling (ESM), while peptides are transformed into SMILES strings and processed by MolFormer to capture chemical and structural properties. Multi-layer cross-attention then refines and integrates these embeddings, highlighting interaction-relevant patterns without requiring explicit structural alignment. Evaluated on the TCHard benchmark under both zero-shot and few-shot settings, TIDE achieves superior predictive accuracy and robustness compared to state-of-the-art baselines such as ChemBERTa, TITAN, and NetTCR. These results demonstrate that combining pretrained language models with cross-attention fusion offers a powerful approach for TCR-pMHC binding prediction and paves the way for more reliable computational immunology applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.